A Phase I Study of OncoVEXGM-CSF, a Second-Generation Oncolytic Herpes Simplex Virus Expressing Granulocyte Macrophage Colony-Stimulating Factor-Reference-Cited by-同舟云学术

A Phase I Study of OncoVEXGM-CSF, a Second-Generation Oncolytic Herpes Simplex Virus Expressing Granulocyte Macrophage Colony-Stimulating Factor

Published:2006-11-15 Issue:22 Volume:12 Page:6737-6747
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Hu Jennifer C.C.,Coffin Robert S.,Davis Ceri J.,Graham Nicola J.,Groves Natasha,Guest Peter J.,Harrington Kevin J.,James Nicholas D.,Love Colin A.,McNeish Iain,Medley Louise C.,Michael Agnieszka,Nutting Christopher M.,Pandha Hardev S.,Shorrock Claire A.,Simpson Julie,Steiner Jan,Steven Neil M.,Wright Dennis,Coombes R. Charles

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 486 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A phase II randomized trial of talimogene laherparepvec oncolytic immunotherapy with or without radiotherapy for patients with cutaneous metastases from solid tumors;Radiotherapy and Oncology;2024-11

2. Disentangling Anti‐Tumor Response of Immunotherapy Combinations: A Physiologically Based Framework for V937 Oncolytic Virus and Pembrolizumab;Clinical Pharmacology & Therapeutics;2024-07-22

3. VP5 protein of oncolytic herpes simplex virus type 2 induces apoptosis in A549 cells through TP53I3 protein;Virology;2024-07

4. Targeting Cancers with oHSV-Based Oncolytic Viral Immunotherapy;Current Issues in Molecular Biology;2024-06-03

5. Intratumoral therapies in head and neck squamous cell carcinoma: A systematic review and future perspectives;Cancer Treatment Reviews;2024-06